Biodegradable Flow Diverter for the Treatment of Intracranial Aneurysms: A Pilot Study Using a Rabbit Aneurysm Model
Open Access
- 15 October 2019
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 8 (20) , e014074
Abstract
Background: Herein, we report an in vivo study of a biodegradable flow diverter ( BDFD ) for aneurysm occlusion. Conceptually, BDFD s induce a temporal flow‐diverting effect and provide a vascular scaffold for neointimal formation at the neck of the aneurysm until occlusion. This offers several potential advantages, including a reduced risk of remote ischemic complications and more treatment options in case of device failure to occlude the aneurysm. Methods and Results: A BDFD consisting of 48 poly‐ l ‐lactic acid wires with radiopaque markers at both ends was prepared. An in vitro degradation test of the BDFD was performed. Thirty‐six BDFD s were implanted in a rabbit aneurysm model. Digital angiography, optical coherence tomography, histopathology, and scanning electron microscopy were performed after 1, 3, and 6 months, and 1 year. The in vitro degradation test showed that the BDFD was almost degraded in 1.5 years. In the in vivo experiment, aneurysm occlusion rates were 0% at 1 month, 20% at 3 months, 50% at 6 months, and 33% at 1 year. Optical coherence tomography showed that luminal area stenosis was the highest at 3 months (16%) and decreased afterward. Immunohistochemical analysis showed that more than half of the luminal surface area was covered by endothelial cells at 1 month. Device fragmentation was not observed in any lesions. Conclusions: This first in vivo study of a BDFD shows the feasibility of using BDFDs for treating aneurysms; however, a longer follow‐up is required for comprehensive evaluation of the biological and mechanical behavior peculiar to biodegradable devices.Keywords
This publication has 34 references indexed in Scilit:
- Long-Term Clinical and Angiographic Outcomes Following Pipeline Embolization Device Treatment of Complex Internal Carotid Artery Aneurysms: Five-Year Results of the Pipeline for Uncoilable or Failed Aneurysms TrialNeurosurgery, 2016
- 1-year outcomes with the Absorb bioresorbable scaffold in patients with coronary artery disease: a patient-level, pooled meta-analysisThe Lancet, 2016
- A Comparison of Functional and Physical Properties of Self-Expanding Intracranial Stents [Neuroform3, Wingspan, Solitaire, Leo(+), Enterprise]min - Minimally Invasive Neurosurgery, 2011
- Very Late Thrombosis of a Pipeline Embolization Device ConstructOperative Neurosurgery, 2010
- An Original Flow Diversion Device for the Treatment of Intracranial AneurysmsStroke, 2009
- Long-Term Patency of Elastase-Induced Aneurysm Model in Rabbits2006
- Degradation of poly-L-lactide. Part 1: in vitro and in vivo physiological temperature degradationProceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine, 2004
- Mechanical properties and in vitro degradation of bioabsorbable self-expanding braided stentsJournal of Biomaterials Science, Polymer Edition, 2003
- Cellular Responses of Bioabsorbable Polymeric Material and Guglielmi Detachable Coil in Experimental AneurysmsStroke, 2002
- Creation of Saccular Aneurysms in the RabbitAmerican Journal of Roentgenology, 2000